Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

2.6K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neural cues differentially modulate colorectal cancer cell behavior depending on patients' genomic background.

iScience·2026
Same author

The Rising Burden of Early-Onset Cancer: Challenges and Opportunities.

Cancer discovery·2026
Same author

WEE1 kinase inhibition to overcome acquired resistance to targeted therapies in colorectal cancer.

EMBO molecular medicine·2026
Same author

Mismatch Repair-Proficient Colorectal Cancer can evade Immune Surveillance Through an Intrinsic Suppressive Program.

Cancer discovery·2026
Same author

Pharmacological inhibition of PMS2 induces MMR deficiency and response to immune checkpoint blockade.

Cancer discovery·2026
Same author

SnapShot: The hallmarks of cancer treatment.

Cell·2026

Related Experiment Video

Updated: Apr 19, 2026

Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment
11:00

Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment

Published on: March 25, 2020

18.0K

Mapping intratumor heterogeneity across layers for advancing immunotherapy.

Jean-Christophe Marine1, Osnat Bartok2, Shira Sagie3

  • 1Laboratory for Molecular Cancer Biology, Center for Cancer Biology, VIB, Leuven, Belgium; Laboratory for Molecular Cancer Biology, Department of Oncology, KULeuven, Leuven, Belgium.

Cell
|April 17, 2026
PubMed
Summary

Intratumor heterogeneity (ITH) creates diverse cancer cell states impacting immune visibility. Understanding these non-mutational changes is key to improving cancer immunotherapy effectiveness and identifying new biomarkers.

More Related Videos

Three-Dimensional Imaging of Tumor-Bearing Tissue Using the Iterative Bleaching Extends Multiplexity Approach
07:16

Three-Dimensional Imaging of Tumor-Bearing Tissue Using the Iterative Bleaching Extends Multiplexity Approach

Published on: April 25, 2025

937
Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors
06:32

Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors

Published on: August 18, 2023

3.4K

Related Experiment Videos

Last Updated: Apr 19, 2026

Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment
11:00

Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment

Published on: March 25, 2020

18.0K
Three-Dimensional Imaging of Tumor-Bearing Tissue Using the Iterative Bleaching Extends Multiplexity Approach
07:16

Three-Dimensional Imaging of Tumor-Bearing Tissue Using the Iterative Bleaching Extends Multiplexity Approach

Published on: April 25, 2025

937
Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors
06:32

Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors

Published on: August 18, 2023

3.4K

Area of Science:

  • Oncology
  • Immunology
  • Genomics

Background:

  • Intratumor heterogeneity (ITH) involves genetic, epigenetic, transcriptional, proteomic, and immunopeptidomic diversity.
  • Non-mutational heterogeneity and plasticity drive dynamic cancer cell states with varying immune visibility.
  • The immunopeptidome, crucial for T cell recognition, is influenced by these diverse cellular states.

Purpose of the Study:

  • To summarize how multidimensional ITH affects cancer types.
  • To explain how ITH constrains immunotherapy efficacy.
  • To propose integrating multi-layered ITH measurements for improved biomarker discovery and treatment strategies.

Main Methods:

  • Review and synthesis of current research on intratumor heterogeneity.
  • Analysis of how different layers of ITH influence cancer cell states and immune recognition.
  • Examination of the impact of ITH on immunotherapy response across various cancer types.

Main Results:

  • Multidimensional ITH, including non-mutational aspects, creates distinct immunological niches.
  • Variations in antigen processing and presentation due to ITH affect immune surveillance and T cell recognition.
  • ITH significantly impacts the efficacy of current immunotherapy strategies.

Conclusions:

  • Integrating multi-omics data to understand ITH is essential for advancing cancer immunology.
  • Addressing ITH complexity can lead to the identification of novel biomarkers for immunotherapy.
  • A comprehensive approach to ITH will enable more precise and effective immune-based cancer treatments.